It works by reducing the formation and accumulation of uric acid in the blood to reduce crystal formation. ADENURIC is used to prevent gout, but is not used to treat acute attacks of gout. Febuxostat is a xanathine oxidase (XO) inhibitor indicated in patients with gout suffering from hyperuricemia and is used in its chronic management. Febuxostat is not recommended for the treatment of asymptomatic hyperuricemia. Febuxostat is marketed under the trade name Uloric by Takeda Pharmaceuticals America, Inc., and was approved by the FDA in February 2009. Febuxostat is an orally available, non-purine inhibitor of xanthine oxidase with uric acid lowering activity.
Pharm Ingredient Febuxostat 99%
In Stock Gout Treatment Powder
Uloric Pharmaceutical Api Gout Dosing
Molecular Formula: C16H16N2O3S
Formula Weight: 316.37
CAS No.: 144060-53-7
Looking for ideal Pharm Ingredient Febuxostat 99% Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the In Stock Gout Treatment Powder are quality guaranteed. We are China Origin Factory of Uloric Pharmaceutical Api Gout Dosing. If you have any question, please feel free to contact us.
Product Categories : Other APIs